A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
In: Annals of Oncology, Jg. 26 (2015-08-01), Heft 8, S. 1547-1573
Online
academicJournal
Zugriff:
Titel: |
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
|
---|---|
Autor/in / Beteiligte Person: | Cherny, N.I. ; Sullivan, R. ; Dafni, U. ; Kerst, J.M. ; Sobrero, A. ; Zielinski, C. ; de Vries, E.G.E. ; Piccart, M.J. |
Link: | |
Zeitschrift: | Annals of Oncology, Jg. 26 (2015-08-01), Heft 8, S. 1547-1573 |
Veröffentlichung: | 2015 |
Medientyp: | academicJournal |
ISSN: | 0923-7534 (electronic) |
DOI: | 10.1093/annonc/mdv249 |
Sonstiges: |
|